Oxford BioDynamics Plc (AIM:OBD)
London · Delayed Price · Currency is GBP · Price in GBX 0.1300
0.00 (0.00%)
Aug 14, 2026, 5:07 PM GMT
Oxford BioDynamics Market Cap
Oxford BioDynamics has a market cap or net worth of 5.58 million as of August 14, 2026. Its market cap has decreased by -33.11% in one year.
Market Cap
5.58M
Enterprise Value
7.35M
Revenue
1.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
ChartMarket Cap Chart
Since December 6, 2016, Oxford BioDynamics's market cap has decreased from 136.90M to 5.58M, a decrease of -95.93%. That is a compound annual growth rate of -28.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 5.58M | -39.53% |
| Dec 31, 2025 | 9.23M | 92.61% |
| Dec 31, 2024 | 4.79M | -91.54% |
| Dec 29, 2023 | 56.64M | 125.13% |
| Dec 30, 2022 | 25.16M | -34.45% |
| Dec 31, 2021 | 38.38M | -50.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 13.96M |
| Fusion Antibodies | 13.14M |
| Genflow Biosciences | 11.04M |
| Solvonis Therapeutics | 10.21M |
| Cizzle Biotechnology Holdings | 7.01M |
| OptiBiotix Health | 5.94M |
| CRISM Therapeutics | 5.83M |
| Thalia Therapeutics | 5.62M |